Nascent Biotech Inc (NBIO)
0.0996
0.00 (0.00%)
USD |
OTCM |
May 22, 15:39
Nascent Biotech Price to Book Value: 556.69 for May 22, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 21, 2024 | 553.90 |
| May 20, 2024 | 553.34 |
| May 17, 2024 | 529.86 |
| May 16, 2024 | 503.04 |
| May 15, 2024 | 545.40 |
| May 14, 2024 | 556.13 |
| May 13, 2024 | 556.13 |
| May 10, 2024 | 557.81 |
| May 09, 2024 | 557.81 |
| May 08, 2024 | 553.34 |
| May 07, 2024 | 549.59 |
| May 06, 2024 | 557.81 |
| May 03, 2024 | 557.81 |
| May 02, 2024 | 557.81 |
| May 01, 2024 | 542.16 |
| April 30, 2024 | 558.37 |
| April 29, 2024 | 558.37 |
| April 26, 2024 | 558.37 |
| April 25, 2024 | 558.37 |
| April 24, 2024 | 558.37 |
| April 23, 2024 | 476.60 |
| April 22, 2024 | 502.20 |
| April 19, 2024 | 523.21 |
| April 18, 2024 | 516.17 |
| April 17, 2024 | 533.78 |
| Date | Value |
|---|---|
| April 16, 2024 | 533.78 |
| April 15, 2024 | 669.04 |
| April 12, 2024 | 613.98 |
| April 11, 2024 | 497.45 |
| April 10, 2024 | 496.33 |
| April 09, 2024 | 496.33 |
| April 08, 2024 | 473.69 |
| April 05, 2024 | 670.71 |
| April 04, 2024 | 950.18 |
| April 03, 2024 | 950.18 |
| April 02, 2024 | 1006.07 |
| April 01, 2024 | 1031.22 |
| March 28, 2024 | 1031.22 |
| March 27, 2024 | 1031.22 |
| March 26, 2024 | 1031.22 |
| March 25, 2024 | 912.45 |
| March 22, 2024 | 1011.66 |
| March 21, 2024 | 1000.48 |
| March 20, 2024 | 816.03 |
| March 19, 2024 | 776.91 |
| March 18, 2024 | 765.73 |
| March 15, 2024 | 765.73 |
| March 14, 2024 | 754.55 |
| March 13, 2024 | 757.35 |
| March 12, 2024 | 758.35 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
473.69
Minimum
Apr 08 2024
1031.22
Maximum
Mar 26 2024
663.49
Average
623.59
Median
Feb 05 2024
Price to Book Value Benchmarks
| NovaBay Pharmaceuticals Inc | -- |
| Palatin Technologies Inc | 20.85 |
| iBio Inc | 0.7735 |
| Theriva Biologics Inc | 0.2081 |
| Oragenics Inc | 11.46 |
Price to Book Value Related Metrics
| Price | 0.0996 |
| Earnings Yield | -15.15% |
| Market Cap | 16.91M |
| Operating PE Ratio | 64.65 |
| Normalized PE Ratio | 11.59 |